Subspecialty	Gastroenterology
Gender	Male
E-mail	mark.babyatsky@mssm.edu
Education and Training	MD, Albert Einstein College of Medicine
	BA, Columbia College
	Residency, Internal Medicine, Mount Sinai Hospital
	Fellowship, Internal Medicine, Massachusetts General Hospital

As Director of the Internal Medicine Residency Program and Vice Chair of Education for the Department of Medicine, Dr. Babyatsky has led a major renovation of the program, helping it become one of the top programs in the country as evidenced by Mount Sinai's ability the top students from the best medical schools. He is currently active nationally in reforming premedical, graduate, and post-graduate curricula for those training to become physicians. Dr. Babyatsky is the Drs. Richard and Mortimer Bader Professor of Medicine.

Dr. Babyatsky is no longer accepting new patients.

Education and Training	MD, Albert Einstein College of Medicine
	BA, Columbia College
	Residency, Internal Medicine, Mount Sinai Hospital
	Fellowship, Internal Medicine, Massachusetts General Hospital
Board Certification	Gastroenterology

Subspecialty	Gastroenterology
Board Certification	Gastroenterology

In his research, Dr. Babyatsky has discovered the critical role played by somatostatin in Inflammatory Bowel Disease. He and his colleagues are now taking this knowledge and applying it to find promising new treatments. In recognition of his research achievements, he has received numerous honors including, multiple awards from the Glaxo Institute for Digestive Health, a Crohn's and Colitis Foundation of America First Award, the Solomon Silver Award from Mount Sinai School of Medicine, membership in the American College of Physicians, and last year he was honored as Man of the Year by the Pamela Beth Deichman Foundation for Crohn's Disease.

Recently, Dr. Babyatsky has become a leader in the emerging field of medical genomics. He is currently writing the first text book on the subject, and he started an internal medicine/medical genetics residency track, one of only a handful in the country.

Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996 April; 110(4): 975-984.

Sarner A, Babyatsky MW. Peptic ulcer disease: paradigms lost [review]. Mt Sinai J Med 1996 October-November; 63(5-6): 387-398.

Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 1996 October; 44(10): 1161-1166.

Dignass AU, Stow JL, Babyatsky MW. Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta. Gut 1996 May; 38(5): 687-693.

Lin J, Holzman IR, Jiang P, Babyatsky MW. Expression of intestinal trefoil factor in developing rat intestine. Biol Neonate 1999 August; 76(2): 92-97.

Eliakim R, Fan QX, Babyatsky MW. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol 2002 June; 14(6): 607-614.

Lin J, Nafday SM, Chauvin SN, Magid MS, Pabbatireddy S, Holzman IR, Babyatsky MW. Variable effects of short chain fatty acids and lactic acid in inducing intestinal mucosal injury in newborn rats. J Pediatr Gastroenterol Nutr 2002 October; 35(4): 545-550.

Lin J, Nadroo AM, Chen W, Holzman IR, Fan QX, Babyatsky MW. Ontogeny and prenatal expression of trefoil factor 3/ITF in the human intestine. Early Hum Dev 2003 April; 71(2): 103-109.

Nafday SM, Chen W, Peng L, Babyatsky MW, Holzman IR, Lin J. Short-chain fatty acids induce colonic mucosal injury in rats with various postnatal ages. Pediatr Res 2005 February; 57(2): 201-204.

Lin J, Peng L, Itzkowitz S, Holzman IR, Babyatsky MW. Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitro. J Pediatr Gastroenterol Nutr 2005 November; 41(5): 607-611.